Medical Case Reports

A 69-year-old male with a past medical history of hypertension and prediabetes presented with worsening fatigue, polyuria, polydipsia, blurry vision, and 14 pounds of weight loss over three weeks that started soon after receiving the 3rd booster dose of BNT162b2 mRNA vaccine. He also reported intermittent upper abdominal pain and episodic ambulatory lightheadedness for two weeks. He also reported a loss of taste and smell for two weeks with a diminished appetite. His family history was significant for some members with Graves' disease and celiac disease. He was a non-smoker with no alcohol or illicit drug use. On examination, he was afebrile with normal blood pressure, sinus tachycardia, and mild tachypnea. Physical exam was remarkable for mild upper abdominal tenderness and dry oral mucosa.  Complete blood count (CBC) was normal; blood glucose was severely elevated with mild corrected hyponatremia; elevated anion gap metabolic acidosis with glucosuria and ketonuria. He recei...

A 25-year-old female developed partial loss of smell 2 days after the injection of the AstraZeneca vaccine (first injection).  The taste evaluation was normal. Patient did not take any medication and did not follow olfactory training. She reported that the smell disorder lasted 10 days. Patient did not report adverse event after the second vaccine injection. A 27-year-old female experienced loss of smell after the first injection of the AstraZeneca vaccine. The patient medical history was unremarkable. She perceived an improvement of smell sense 9 days after the vaccine without olfactory training or medical treatment. Patient did not report adverse event after the second vaccine injection.  A 51-year-old female developed total loss of smell 2 days after the first injection of AstraZeneca vaccine. She also reported arthralgia, fever, and chills during a few days. The total loss of smell persisted one week with a subsequent progressive improvement of smell. The patient report...